{"id":110239,"name":"AMFAR THE FOUNDATION FOR AIDS RESEARCH","slug":"amfar-the-foundation-for-aids-research","state":"NY","country":"United States of America","description":"HIV/AIDS research","totalSpending":480000,"filings":33,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":30000},{"year":2021,"income":0},{"year":2022,"income":20000},{"year":2023,"income":120000},{"year":2024,"income":70000},{"year":2025,"income":0}],"issues":[{"code":"FOR","display":"Foreign Relations"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"}],"firms":["BROWNSTEIN HYATT FARBER SCHRECK, LLP"],"lobbyists":["CATE BLANKENBURG","ZACHARY PFISTER","BRIAN WILD","PETER GOODLOE","BRIAN MCKEON","DAVID REID","ARACELI GUTIERREZ","ANDREW LITTMAN","HEATHER WADYKA","ADAM STEINMETZ","SAGE SCHAFTEL","NADEAM ELSHAMI","LAUREN DIEKMAN","BRIAN MCGUIRE","ANDREW USYK"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Centers For Disease Control & Prevention (CDC)","Office of Natl Drug Control Policy (NDCP)","State, Dept of (DOS)"],"sampleDescriptions":["HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention an","HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention an","HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention an","HIV/AIDS funding issues","Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care"]}